Merck brings contract sales reps onboard

Share this article:
Merck announced a strategic partnership with inVentiv Health, whereby Merck will utilize inVentiv's contract sales staff to supplement Merck's in-house sales force.

The move comes in the wake of Merck's elimination of 15% of its U.S. sales force (1,200 jobs) four months ago.

According to a Dow Jones Newswire report, Whitehouse Station, NJ-based Merck, rather than recruit, hire or keep full-time representatives on the books, has decided to create a more flexible approach so as the market demands change, Merck can expand and contract the number of reps that is has at its disposal.

Merck didn't reveal how many inVentiv reps will be recruited or which drugs they'll be promoting. However, according to the Dow Jones report, the partnership does not include vaccines or drugs marketed to oncologists, ophthalmologists, or dermatologists.

InVentiv's Marcia Frederick said the company is seeing an upswing in its contract sales force business.

Separately, InVentiv announced that it has ended a contract with Boehringer Ingelheim, while initiating nine new sales team agreements including Merck.

 


Share this article:

Email Newsletters

More in News

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...

Bayer drug gets orphan label

Bayer drug gets orphan label

The FDA designation is for an experimental, inhaled form of ciprofloxacin intended to treat a rare lung condition.

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.